Comparing the Role of Mechanical Forces in Vascular and Valvular Calcification Progression

Frontiers in Cardiovascular Medicine

Volumn 5, Issue , 2019, Pages

  Gomel, Madeleine A ^a   Lee, Romi ^a   Grande Allen, K Jane ^a  

^a Rice University   (United States)

Author keywords

atherosclerosis; biomechanics; CAVD; oscillatory stress; shear stress; valvular calcification; vascular calcification

Indexed keywords

ANATOMY; ANKLE BRACHIAL INDEX; AORTIC ENDOTHELIAL CELL; AORTIC VALVE; AORTIC VALVE CALCIFICATION; AORTIC VALVE STENOSIS; ARTERIAL STIFFNESS; BASILAR ARTERY; BIOCOMPATIBILITY; BIOMECHANICS; BLOOD FLOW; BLOOD VESSEL CALCIFICATION; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; CARDIOVASCULAR RISK; CELL FUNCTION; COMPARATIVE STUDY; DISEASE EXACERBATION; DOWN REGULATION; ELEMENTAL ANALYSIS; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; HEART CYCLE; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEMODYNAMICS; HUMAN; MECHANICAL FORCE; MECHANICAL STIMULATION; MECHANOBIOLOGY; OSCILLATION; PATHOLOGY; PHYSICAL PARAMETERS; REVASCULARIZATION; REVIEW; RISK FACTOR; SHEAR STRESS; TISSUE ENGINEERING; TISSUE REGENERATION; TUNICA EXTERNA; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL;

EID: 85066240953     PISSN: None     EISSN: 2297055X     Source Type: Journal    
DOI: 10.3389/fcvm.2018.00197     Document Type: Review

References (127)

1. Warren BA, Yong JLC. Calcification of the aortic valve: its progression and grading. Pathology (1997) 29:360–8. 10.1080/003130297001693159423215
2. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart Disease and Stroke Statistics-2018 Update: A Report from the American Heart Association (2018). 10.1161/CIR.000000000000048529386200
3. Goldbarg SH, Elmariah S, Miller MA, Fuster V. Insights into degenerative aortic valve disease. J Am Coll Cardiol. (2007) 50:1205–13. 10.1016/j.jacc.2007.06.02417888836
4. Pomerance A. Ageing changes in human heart valves. Br Heart J. (1967) 29:222–31. 6020817
5. Misfeld M, Sievers HH. Heart valve macro- and microstructure. Philos Trans R Soc B Biol Sci. (2007) 362:1421–36. 10.1098/rstb.2007.212517581807
6. Allison MA, Criqui MH, Wright CM. Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol. (2004) 24:331–6. 10.1161/01.ATV.0000110786.02097.0c14656730
7. Boström KI, Rajamannan NM, Towler DA. The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ Res. (2011) 109:564–77. 10.1161/CIRCRESAHA.110.23427821852555
8. Abedin M, Tintut Y, Demer LL. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol. (2004) 37:2252–9. 10.1161/01.ATV.0000133194.94939.42
9. Zhu D, Mackenzie NCW, Farquharson C, MacRae VE. Mechanisms and clinical consequences of vascular calcification. Front Endocrinol. (2012) 3:1–12. 10.3389/fendo.2012.0009522888324
10. Karwowski W, Naumnik B, Szczepanski M, Myśliwiec M. The mechanism of vascular calcification – a systematic review. Med Sci Monit. (2012) 18:RA1–11. 10.12659/MSM.88218122207127
11. Huang H, Virmani R, Younis H, Burke AP, Kamm RD, Lee RT. The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation (2001) 103:1051–6. 10.1161/01.CIR.103.8.105111222465
12. Sacks MS, David Merryman W, Schmidt DE. On the biomechanics of heart valve function. J Biomech. (2009) 42:1804–24. 10.1016/j.jbiomech.2009.05.01519540499
13. Bäck M, Gasser TC, Michel JB, Caligiuri G. Biomechanical factors in the biology of aortic wall and aortic valve diseases. Cardiovasc Res. (2013) 99:232–41. 10.1093/cvr/cvt04023459103
14. Broom ND. The observation of collagen and elastin structures in wet whole mounts of pulmonary and aortic leaflets. J Thorac Cardiovasc Surg. (1978) 75:121–30. 339002
15. Mehta SM, Jin T, Stanciulescu I, Grande-Allen KJ. Engineering biologically extensible hydrogels using photolithographic printing. Acta Biomater. (2018) 75:52–62. 10.1016/j.actbio.2018.05.03629803005
16. Villari B, Campbell SE, Hess OM, Mall G, Vassalli G, Weber KT, et al. Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease. J Am Coll Cardiol. (1993) 22:1477–84. 10.1016/0735-1097(93)90560-N8227808
17. De Hart J, Peters GWM, Schreurs PJG, Baaijens FPT. Collagen fibers reduce stresses and stabilize motion of aortic valve leaflets during systole. J Biomech. (2004) 37:303–11. 10.1016/S0021-9290(03)00293-814757449
18. Sacks MS, Smith DB, Hiester ED. The aortic valve microstructure: effects of transvalvular pressure. J Biomed Mater Res. (1998) 41:131–41. 9641633
19. Latif N, Sarathchandra P, Taylor PM, Antoniw J, Yacoub MH. Localization and pattern of expression of extracellular matrix components in human heart valves. J Heart Valve Dis. (2005) 14:218–27. 15792183
20. Scott M, Vesely I. Aortic valve cusp microstructure: the role of elastin. Ann Thorac Surg. (1995) 60:S391–4. 10.1016/0003-4975(95)00263-K7646194
21. Eriksen HA, Satta J, Risteli J, Veijola M, Väre P, Soini Y. Type I and type III collagen synthesis and composition in the valve matrix in aortic valve stenosis. Atherosclerosis (2006) 189:91–8. 10.1016/J.ATHEROSCLEROSIS.2005.11.03416405893
22. Allison DD, Grande-Allen KJ. Review. Hyaluronan: a powerful tissue engineering tool. Tissue Eng. (2006) 12:2131–40. 10.1089/ten.2006.12.213116968154
23. Stephens EH, Chu C-K, Grande-Allen KJ. Valve proteoglycan content and glycosaminoglycan fine structure are unique to microstructure, mechanical load and age: relevance to an age-specific tissue-engineered heart valve. Acta Biomater. (2008) 4:1148–60. 10.1016/J.ACTBIO.2008.03.01418448399
24. García-Cardeña G, Slegtenhorst BR. Hemodynamic control of endothelial cell fates in development. Annu Rev Cell Dev Biol. (2016) 32:633–48. 10.1146/annurev-cellbio-100814-12561027712101
25. Shapero K, Wylie-Sears J, Levine RA, Mayer JE, Bischoff J. Reciprocal interactions between mitral valve endothelial and interstitial cells reduce endothelial-to-mesenchymal transition and myofibroblastic activation. J Mol Cell Cardiol. (2015) 80:175–85. 10.1016/j.yjmcc.2015.01.00625633835
26. Hjortnaes J, Shapero K, Goettsch C, Hutcheson JD, Kluin J, Mayer JE, et al. Valvular interstitial cells suppress calcification of valvular endothelial cells. Atherosclerosiss (2015) 242:251–60. 10.1016/j.atherosclerosis.2015.07.008.Valvular26232165
27. * executive summary: calcific aortic valve disease - 2011 update. Circulation (2011) 124:1783–91. 10.1161/CIRCULATIONAHA.110.006767
28. Hinton RB. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res. (2006) 98:1431–8. 10.1161/01.RES.0000224114.65109.4e16645142
29. Paranya G, Vineberg S, Dvorin S, Kaushal S, Roth SJ, Rabkin E, et al. Aortic valve endothelial cells undergo transforming growth factor-β-mediated and non-transforming growth factor-β-mediated transdifferentiation in vitro. Am J Pathol. (2001) 159:1335–43. 10.1016/S0002-9440(10)62520-511583961
30. Yip CYY, Chen JH, Zhao R, Simmons CA. Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Arterioscler Thromb Vasc Biol. (2009) 29:936–42. 10.1161/ATVBAHA.108.18239419304575
31. Li C, Xu S, Gotlieb AI. The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops. Cardiovasc Pathol. (2013) 22:1–8. 10.1016/J.CARPATH.2012.06.00522795219
32. Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA. Valvular myofibroblast activation by transforming growth factor-: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res. (2004) 95:253–60. 10.1161/01.RES.0000136520.07995.aa15217906
33. van Geemen D, Soares ALF, Oomen PJA, Driessen-Mol A, Janssen-van den Broek MWJT, van den Bogaerdt AJ, et al. Age-Dependent changes in geometry, tissue composition and mechanical properties of fetal to adult cryopreserved human heart valves. PLoS ONE (2016) 11:e0149020. 10.1371/journal.pone.014902026867221
34. Liu AC, Joag VR, Gotlieb AI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol. (2007) 171:1407–18. 10.2353/AJPATH.2007.07025117823281
35. Rodriguez KJ, Masters KS. Regulation of valvular interstitial cell calcification by components of the extracellular matrix. J Biomed Mater Res Part A (2009) 90A:1043–53. 10.1002/jbm.a.32187
36. Jian B, Jones PL, Li Q, Mohler ER, Schoen FJ, Levy RJ. Matrix Metalloproteinase-2 is associated with tenascin-c in calcific aortic stenosis. Am J Pathol. (2001) 159:321–7. 10.1016/S0002-9440(10)61698-711438479
37. Blaser MC, Wei K, Adams RLE, Zhou Y-Q, Caruso L, Mirzaei Z, et al. Deficiency of natriuretic peptide receptor 2 promotes bicuspid aortic valves, aortic valve disease, left ventricular dysfunction, and ascending aortic dilatations in mice. Circ Res. (2018) 122:405–16. 10.1161/CIRCRESAHA.117.31119429273600
38. Wagenseil JE, Mecham RP. Vascular extracellular matrix and arterial mechanics. Physiol Rev. (2009) 89:957–89. 10.1152/physrev.00041.200819584318
39. Wolinsky H, Glagov S. A Lamellar unit of aortic medial structure and function in mammals. Circ Res. (1967) 20:99–111. 4959753
40. Avolio A, Jones D, Tafazzoli-Shadpour M. Quantification of alterations in structure and function of elastin in the arterial media. Hypertension (1998) 32:170–5. 9674656
41. Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res. (2016) 118:692–702. 10.1161/CIRCRESAHA.115.30636126892967
42. Wang D, Uhrin P, Mocan A, Waltenberger B, Breuss JM, Tewari D, et al. Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways. Biotechnol Adv. (2018) 36:1586–607. 10.1016/J.BIOTECHADV.2018.04.006
43. Hinton RB, Yutzey KE. Heart valve structure and function in development and disease. Annu Rev Physiol. (2011) 73:29–46. 10.1146/annurev-physiol-012110-14214520809794
44. Vesely I, Noseworthy R. Micromechanics of the fibrosa and the ventricularis in aortic valve leaflets. J Biomech. (1992) 25:101–13. 10.1016/0021-9290(92)90249-Z1733978
45. Cao K, BukaC M, Sucosky P. Three-dimensional macro-scale assessment of regional and temporal wall shear stress characteristics on aortic valve leaflets. Comput Methods Biomech Biomed Eng. (2016) 19:603–13. 10.1080/10255842.2015.105241926155915
46. Malek AM, Alper SL. Hemodynamic shear stress and its role in atherosclerosis. JAMA (1999) 282:2035–42. 10591386
47. Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling. molecular, cellular, and vascular behavior. J Am Coll Cardiol. (2007) 49:2379–93. 10.1016/j.jacc.2007.02.05917599600
48. Chiu J-J, Chien S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev. (2011) 91:327–387. 10.1152/physrev.00047.200921248169
49. Vanhoutte PM, Shimokawa H, Tang EHC, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol. (2009) 196:193–222. 10.1111/j.1748-1716.2009.01964.x19220204
50. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med. (2000) 343:611–7. 10.1056/NEJM20000831343090310965007
51. Mohler ER, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation (2001) 103:1522–8. 10.1161/01.CIR.103.11.152211257079
52. Halevi R, Hamdan A, Marom G, Mega M, Raanani E, Haj-Ali R. Progressive aortic valve calcification: three-dimensional visualization and biomechanical analysis. J Biomech. (2015) 48:489–97. 10.1016/j.jbiomech.2014.12.00425553668
53. Thubrikar J, Aouad J, Nolan SP. Patterns of calcific deposits in operatively excised stenotic or purely degurgitant aortic valves and their relation to mechanical stress. Am J Cardiol. (1986) 58:304–8. 3739919
54. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation (2005) 111:3316–26. 10.1161/CIRCULATIONAHA.104.48673815967862
55. Feuchtner GM, Dichtl W, Friedrich GJ, Frick M, Alber H, Schachner T, et al. Multislice computed tomography for detection of patients with aortic valve stenosis and quantification of severity. J Am Coll Cardiol. (2006) 47:1410–7. 10.1016/j.jacc.2005.11.05616580530
56. Masjedi S, Amarnath A, Baily KM, Ferdous Z. Comparison of calcification potential of valvular interstitial cells isolated from individual aortic valve cusps. Cardiovasc Pathol. (2016) 25:185–94. 10.1016/j.carpath.2015.12.00226874039
57. Ge L, Sotiropoulos F. Direction and magnitude of blood flow shear stresses on the leaflets of aortic valves: is there a link with valve calcification? J Biomech Eng. (2009) 132:14505. 10.1115/1.400016220524753
58. Simmons CA. Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves. Circ Res. (2005) 96:792–9. 10.1161/01.RES.0000161998.92009.6415761200
59. Arzani A, Mofrad MRK. A strain-based finite element model for calcification progression in aortic valves. J Biomech. (2017) 65:216–20. 10.1016/j.jbiomech.2017.10.01429100595
60. Chen J-H, Simmons CA, Towler DA. Cell-matrix interactions in the pathobiology of calcific aortic valve disease: critical roles for matricellular, matricrine, and matrix mechanics cues. Circ Res. (2011) 108:1510–24. 10.1161/CIRCRESAHA.110.23423721659654
61. Hutson HN, Marohl T, Anderson M, Eliceiri K, Campagnola P, Masters KS. Calcific aortic valve disease is associated with layer-specific alterations in collagen architecture. PLoS ONE (2016) 11:e0163858. 10.1371/journal.pone.016385827685946
62. Caira FC, Stock SR, Gleason TG, McGee EC, Huang J, Bonow RO, et al. Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol. (2006) 47:1707–12. 10.1016/j.jacc.2006.02.04016631011
63. Rajamannan NM. Oxidative-mechanical stress signals stem cell niche mediated Lrp5 osteogenesis in eNOS–/– null mice. J Cell Biochem. (2011) 113:1623–34. 10.1002/jcb.2403122359381
64. Garg V. Notch signaling in aortic valve development and disease. In: Nakanishi T, Markwald RR, Baldwin HS, Keller BB, Srivastava D, Yamagishi H, editors. Etiology and Morphogenesis of Congenital Heart Disease. Tokyo: Springer (2016). p. 371–6. 10.1007/978-4-431-54628-3_53
65. Mathieu P, Bossé Y, Huggins GS, Corte A, Della Pibarot P, Michelena HI, et al. The pathology and pathobiology of bicuspid aortic valve: state of the art and novel research perspectives. J Pathol Clin Res. (2015) 1:195–206. 10.1002/cjp2.2127499904
66. Roos C, Hagler M, Versoza G, Bin Z, Thalji N, Richardson A, Miller J. Overexpression of mnsod reduces aortic valve calcification through repression of pro-osteogenic signaling. Arterioscler Thromb Vasc Biol. (2015) 35:A582–2. 10.1161/atvb.35.suppl_1.582
67. Butcher JT, Nerem RM. Valvular endothelial cells and the mechanoregulation of valvular pathology. Philos Trans R Soc B Biol Sci. (2007) 362:1445–57. 10.1098/rstb.2007.212717569641
68. Weinberg EJ, Mack PJ, Schoen FJ, García-Cardeña G, Kaazempur Mofrad MR. Hemodynamic environments from opposing sides of human aortic valve leaflets evoke distinct endothelial phenotypes in vitro. Cardiovasc Eng. (2010) 10:5–11. 10.1007/s10558-009-9089-920107896
69. White MP, Theodoris CV, Liu L, Collins WJ, Blue KW, Lee JH, et al. NOTCH1 regulates matrix gla protein and calcification gene networks in human valve endothelium. J Mol Cell Cardiol. (2015) 84:13–23. 10.1016/j.yjmcc.2015.04.00625871831
70. Mahler GJ, Frendl CM, Cao Q, Butcher JT. Effects of shear stress pattern and magnitude on mesenchymal transformation and invasion of aortic valve endothelial cells. Biotechnol Bioeng. (2014) 111:2326–37. 10.1002/bit.2529124898772
71. Towler D. Molecular and cellular aspects of calcific aortic valve disease. Circ Res. (2013) 113:198–208. 10.1161/CIRCRESAHA.113.30015523833294
72. Coté N, Mahmut A, Bosse Y, Couture C, Pagé S, Trahan S, et al. Inflammation is associated with the remodeling of calcific aortic valve disease. Inflammation (2013) 36:573–81. 10.1007/s10753-012-9579-623225202
73. Otto CM, Kuusisto J, Reichenbach D, Gown A, O'brien K. Characterization of the early lesion of degenerative valvular aortic stenosis. Circulation (1994) 90:844–53. 7519131
74. Mathieu P, Boulanger M-C. Basic mechanisms of calcific aortic valve disease. Can J Cardiol. (2014) 30:982–93. 10.1016/j.cjca.2014.03.02925085215
75. Bosse K, Hans CP, Zhao N, Koenig SN, Huang N, Guggilam A, et al. Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease. J Mol Cell Cardiol. (2013) 60:27–35. 10.1016/J.YJMCC.2013.04.00123583836
76. Richards J, El-Hamamsy I, Chen S, Sarang Z, Sarathchandra P, Yacoub MH, et al. Side-specific endothelial-dependent regulation of aortic valve calcification: interplay of hemodynamics and nitric oxide signaling. Am J Pathol. (2013) 182:1922–31. 10.1016/J.AJPATH.2013.01.03723499458
77. Rajamannan NM, Subramaniam M, Stock SR, Stone NJ, Springett M, Ignatiev KI, et al. Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart (2005) 91:806–10. 10.1136/hrt.2003.02978515894785
78. Kennedy JA, Hua X, Mishra K, Murphy GA, Rosenkranz AC, Horowitz JD. Inhibition of calcifying nodule formation in cultured porcine aortic valve cells by nitric oxide donors. Eur J Pharmacol. (2009) 602:28–35. 10.1016/j.ejphar.2008.11.02919056377
79. Miller JD, Chu Y, Brooks RM, Richenbacher WE, Peña-Silva R, Heistad DD. Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. J Am Coll Cardiol. (2008) 52:843–50. 10.1016/j.jacc.2008.05.04318755348
80. Mabry KM, Lawrence RL, Anseth KS. Dynamic stiffening of poly(ethylene glycol)-based hydrogels to direct valvular interstitial cell phenotype in a three-dimensional environment. Biomaterials (2015) 49:47–56. 10.1016/j.biomaterials.2015.01.04725725554
81. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. (2002) 3:349–63. 10.1038/nrm80911988769
82. Chen J-H, Yip CYY, Sone ED, Simmons CA. Identification and characterization of aortic valve mesenchymal progenitor cells with robust osteogenic calcification potential. Am J Pathol. (2009) 174:1109–19. 10.2353/AJPATH.2009.08075019218344
83. van Thienen J, Fledderus J, Dekker R, Rohlena J, van IJzendoorn G, Kootstra N, et al. Shear stress sustains atheroprotective endothelial KLF2 expression more potently than statins through mRNA stabilization. Cardiovasc Res. (2006) 72:231–40. 10.1016/j.cardiores.2006.07.00816945356
84. Demer LL, Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation (2008) 117:2938–48. 10.1161/CIRCULATIONAHA.107.74316118519861
85. Boström KI, Yao J, Guihard PJ, Blazquez-Medela AM, Yao Y. Endothelial-mesenchymal transition in atherosclerotic lesion calcification. Atherosclerosis (2016) 253:124–7. 10.1016/j.atherosclerosis.2016.08.04627615595
86. Ku DN, Giddens DP, Zarins CK, Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arterioscler Thromb Vasc Biol. (1985) 5:293–302. 10.1161/01.ATV.5.3.2933994585
87. Tarbell JM, Shi Z-D, Dunn J, Jo H. Fluid Mechanics, Arterial disease, and gene expression. Annu Rev Fluid Mech. (2014) 46:591–614. 10.1146/annurev-fluid-010313-14130925360054
88. Ku DN. Blood flow in arteries. Annu Rev Fluid Mech. (1997) 29:399–434. 10.1146/annurev.fluid.29.1.399
89. Wada T, McKee MD, Steitz S, Giachelli CM. Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ Res. (1999) 84:166–78. 10.1161/01.RES.84.2.1669933248
90. Speer MY, McKee MD, Guldberg RE, Liaw L, Yang H-Y, Tung E, et al. Inactivation of the osteopontin gene enhances vascular calcification of matrix gla protein–deficient mice. J Exp Med. (2002) 196:1047–55. 10.1084/jem.2002091112391016
91. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protien. Nature (1997) 386:78–81. 10.1038/386078a09052783
92. Yao J, Guihard PJ, Blazquez-Medela AM, Guo Y, Moon J, Jumabay M, et al. Serine protease activation essential for endothelial–mesenchymal transition in vascular calcification. Circ Res. (2015) 117:758–69. 10.1161/CIRCRESAHA.115.30675126265629
93. Farzaneh-Far A, Proudfoot D, Weissberg PL, Shanahan CM. Matrix Gla protein is regulated by a mechanism functionally related to the calcium-sensing receptor. Biochem Biophys Res Commun. (2000) 277:736–40. 10.1006/bbrc.2000.374711062022
94. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. (1998) 12:1260–8. 10.1101/gad.12.9.12609573043
95. Swaminathan G, Gadepalli VS, Stoilov I, Mecham RP, Rao RR, Ramamurthi A. Pro-elastogenic effects of bone marrow mesenchymal stem cell-derived smooth muscle cells on cultured aneurysmal smooth muscle cells. J Tissue Eng Regen Med. (2014) 11:679–93. 10.1002/term.196425376929
96. Sivaraman B, Bashur CA, Ramamurthi A. Advances in biomimetic regeneration of elastic matrix structures. Drug Deliv Transl Res. (2012) 2:323–50. 10.1007/s13346-012-0070-623355960
97. Ameer OZ, Salman IM, Avolio AP, Phillips JK, Butlin M. Opposing changes in thoracic and abdominal aortic biomechanical properties in rodent models of vascular calcification and hypertension. AJP Hear Circ Physiol. (2014) 307:H143–51. 10.1152/ajpheart.00139.201424838503
98. Lehto S, Niskanen L, Suhonen M, Rönnemaa T, Laakso M. Medial artery calcification: a neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. (1996) 16:978–83. 10.1161/01.ATV.16.8.9788696962
99. Lanzer P, Boehm M, Sorribas V, Thiriet M, Janzen J, Zeller T, et al. Medial vascular calcification revisited: review and perspectives. Eur Heart J. (2014) 35:1515–25. 10.1093/eurheartj/ehu16324740885
100. Rutkovskiy A, Malashicheva A, Sullivan G, Bogdanova M, Kostareva A, Stensløkken KO, et al. Valve interstitial cells: the key to understanding the pathophysiology of heart valve calcification. J Am Heart Assoc. (2017) 6:e006339. 10.1161/JAHA.117.00633928912209
101. Simard T, Hibbert B, Ramirez FD, Froeschl M, Chen YX, O'Brien ER. The evolution of coronary stents: a brief review. Can J Cardiol. (2014) 30:35–45. 10.1016/j.cjca.2013.09.01224286961
102. Tohno Y, Tohno S, Minami T, Ichii M, Okazaki Y, Utsumi M, et al. Age-related change of mineral content in the human thoracic aorta and in the human cerebral artery. Biol Trace Elem Res. (1996) 54:23–31. 8862758
103. Brandenburg VM, Reinartz S, Kaesler N, Krüger T, Dirrichs T, Kramann R, et al. Slower progress of aortic valve calcification with Vitamin K supplementation: results from a prospective interventional proof-of-concept study. Circulation (2017) 135:2081–3. 10.1161/CIRCULATIONAHA.116.02701128533322
104. Blum K, Drews J, Breuer CK. Tissue engineered heart valves: a call for mechanistic studies. Tissue Eng Part B Rev. (2018) 24:240–53. 10.1089/ten.TEB.2017.042529327671
105. Goldstone AB, Chiu P, Baiocchi M, Lingala B, Patrick WL, Fischbein MP, et al. Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement. N Engl J Med. (2017) 377:1847–57. 10.1056/NEJMoa161379229117490
106. Puri R, Auffret V. Bioprosthetic valve thrombosis. J Am Coll Cardiol. (2017) 69:2193–211. 10.1016/j.jacc.2017.02.05128449781
107. Kheradvar A, Groves EM, Dasi LP, Alavi SH, Tranquillo R, Grande-Allen KJ, et al. Emerging trends in heart valve engineering: part i. solutions for future. Ann Biomed Eng. (2015) 43:833–43. 10.1007/s10439-014-1209-z
108. Batlivala SP, Emani S, Mayer JE, McElhinney DB. Pulmonary valve replacement function in adolescents: a comparison of bioprosthetic valves and homograft conduits. Ann Thorac Surg. (2012) 93:2007–16. 10.1016/j.athoracsur.2012.02.03922560964
109. Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet (2000) 356:1403–5. 10.1016/S0140-6736(00)02844-011052583
110. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. (2010) 363:1597–607. 10.1056/NEJMoa100823220961243
111. Gilard M, Boschat J. Transcatheter aortic valve implantation. In: Presbitero P, Mehilli J, Petronio A, editors. Percutaneous Treatment of Cardiovascular Diseases in Women. Cham: Springer (2017). 10.1007/978-3-319-39611-8_8
112. Simmons CA. Taking bioengineered heart valves from faulty to functional. Nature (2018) 559:42–3. 10.1038/d41586-018-05566-329967382
113. Lintas V, Fioretta E, Dijkman P, Caliskan E, Rodriguez H, Cesarovic N, et al. Human cell derived off-the-shelf Tissue engineered heart valves for next generation transcatheter aortic valve replacement: a proof-of-concept study in adult sheep. J Am Coll Cardiol. (2017) 70:B271. 10.1016/j.jacc.2017.09.679
114. Dijkman PE, Driessen-Mol A, de Heer LM, Kluin J, van Herwerden LA, Odermatt B, et al. Trans-apical versus surgical implantation of autologous ovine tissue-engineered heart valves. J Heart Valve Dis. (2012) 21:670–−8. 23167234
115. Parvin Nejad S, Blaser MC, Santerre JP, Caldarone CA, Simmons CA. Biomechanical conditioning of tissue engineered heart valves: too much of a good thing? Adv Drug Deliv Rev. (2016) 96:161–75. 10.1016/J.ADDR.2015.11.00326555371
116. Saleeb SF, Newburger JW, Geva T, Baird CW, Gauvreau K, Padera RF, et al. Accelerated degeneration of a bovine pericardial bioprosthetic aortic valve in children and young adults. Circulation (2014) 130:51–60. 10.1161/CIRCULATIONAHA.114.00983524756063
117. Zubairi R, Malik S, Jaquiss RDB, Imamura M, Gossett J, Morrow WR. Risk factors for prosthesis failure in pulmonary valve replacement. Ann Thorac Surg. (2011) 91:561–5. 10.1016/j.athoracsur.2010.07.11121256315
118. Mendelson K, Schoen FJ. Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng. (2006) 34:1799–819. 10.1007/s10439-006-9163-z17053986
119. Emmert MY, Schmitt BA, Loerakker S, Sanders B, Spriestersbach H, Fioretta ES, et al. Computational modeling guides tissue-engineered heart valve design for long-term in vivo performance in a translational sheep model. Sci Transl Med. (2018) 10:eaan4587. 10.1126/scitranslmed.aan458729743347
120. Emmert MY, Hoerstrup SP. Challenges in translating tissue engineered heart valves into clinical practice. Eur Heart J. (2017) 38:619–21. 10.1093/eurheartj/ehx07529121258
121. O'Neill WC, Lomashvili KA. Recent progress in the treatment of vascular calcification. Kidney Int. (2010) 78:1232–9. 10.1038/ki.2010.33420861819
122. Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, et al. Statin-associated muscle symptoms: impact on statin therapy—European atherosclerosis society consensus panel statement on assessment, aetiology and management. Eur Heart J. (2015) 36:1012–22. 10.1093/eurheartj/ehv04325694464
123. Nissen SE, Nicholls SJ, Sipahi I. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the asteroid trial. JAMA (2006) 295:1556–65. 10.1001/jama.295.13.jpc6000216533939
124. Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MHJ, Meer IM, et al. Nutritional epidemiology dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the rotterdam study 1. J Nutr. (2004)134:3100–5. 10.1093/jn/134.11.3100
125. Beulens JWJ, Bots ML, Atsma F, Bartelink MLEL, Prokop M, Geleijnse JM, et al. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis (2009) 203:489–93. 10.1016/j.atherosclerosis.2008.07.01018722618
126. MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet (2004) 363:1491–502. 10.1016/S0140-6736(04)16146-1
127. Paraskevas KI, Robertson V, Saratzis AN, Naylor AR. Editor's Choice-An updated systematic review and meta-analysis of outcomes following eversion vs. conventional carotid endarterectomy in randomised controlled trials and observational studies. Eur J Vasc Endovasc Surg. (2018) 55:465–73. 10.1016/j.ejvs.2017.12.02529426593